ISRG
Intuitive Surgical Inc
How Do They Make Money?
How Do They Make Money?Business Model:
Intuitive Surgical develops, manufactures, and markets robotic-assisted surgical systems, primarily the da Vinci Surgical System.
Their strategy is a razor-and-blades model:
Sell the robot (capital equipment).
Earn recurring revenue from instruments, accessories, service contracts, and leasing tied to procedure volume.
1.Revenue Streams
Systems (Capital Equipment)
Each da Vinci system costs between $0.7–3.1 million, depending on model and configuration.
Hospitals either buy outright or lease via Intuitive’s financing programs.
2024 systems revenue: $1.97 billion (+17% YoY).
Systems placed in 2024: 1,526 units, including 362 da Vinci 5 systems.
Installed base (Dec 31, 2024): ~9,902 systems worldwide (up ~15% YoY).
While lumpy and less predictable, these sales are the gateway to recurring revenue streams.
Instruments & Accessories (Consumables)
Disposable or limited-use surgical tools (e.g., staplers, forceps, scissors).
Each instrument has a usage limit (often ~10 uses) before replacement.
Revenue scales directly with procedure volume.
2024 instruments & accessories revenue: $5.08 billion (+19% YoY).
Accounts for ~60% of total company revenue.
Per-procedure revenue: ~$800–3,600, depending on case complexity.
This is the largest and most profitable revenue driver, providing annuity-like cash flows.
Services & Maintenance
Multi-year contracts for system servicing, calibration, software upgrades, and technical support.
Mandatory for hospitals to keep da Vinci systems functional.
2024 service revenue: $1.31 billion (+12% YoY).
Provides predictable, high-margin revenue that smooths cyclicality of system sales.
Leasing & Financing
Flexible acquisition models: operating leases, usage-based payments, and hybrid financing.
Makes adoption easier for hospitals facing budget constraints.
Leasing revenue is recognized partly as recurring revenue.
Expands adoption and locks in future consumable/service streams.
Recurring vs Non-Recurring Revenue
Recurring revenue (consumables, service, leasing): $7.04 billion in 2024 (~84% of total).
This share grew from 79% in 2022 → 83% in 2023 → 84% in 2024.
Recurring revenues now dominate, making Intuitive less reliant on volatile hardware sales.
Procedure Volumes (Growth Engine)
2024: ~2.68 million procedures, up 17% from ~2.29 million in 2023.
Q4 2024: +18% YoY procedure growth.
U.S. general surgery +19%; international growth +23%.
2025 procedure growth forecast:13–16%.
Every additional procedure → more instrument consumption + higher service utilization.
Margins & Profitability
2024 gross margin: ~69.1% of revenue.
Forecast 2025: 65–66.5%, pressured by tariffs (~1.7% revenue impact) and higher costs.
Despite margin headwinds, the mix of recurring revenue stabilizes profitabil
How Intuitive Makes Money:
Place robots in hospitals (via sales or leases).
Surgeons perform procedures → consumable instruments are used, generating recurring revenue.
Hospitals sign service contracts to ensure system uptime.
Financing and leasing models broaden access and secure future recurring revenues.
Procedure growth drives the flywheel: more surgeries → more instrument usage → higher recurring revenue share.
This creates a self-reinforcing cycle: larger installed base → more procedures → more consumables & service revenue → more hospital adoption.
Summary:
Intuitive Surgical’s revenue engine is built on recurring, procedure-driven sales rather than one-off hardware.
Systems sales (~$2B/year) expand the installed base.
Consumables (instruments & accessories) (~$5B/year) scale with procedure volumes, providing the largest, high-margin revenue stream.
Services & maintenance (~$1.3B/year) lock hospitals into long-term contracts.
Leasing & financing reduce adoption friction, ensuring expansion.
Intuitive makes money by selling hospitals very expensive robots — but the real profits come from every surgery performed afterward. It is a tollbooth on the highway of robotic surgery, with recurring revenues now comprising ~84% of total sales.
Visualizations(see below for problems and comments):
Solid Data: Total revenue (2015–2024), Installed base (2016–2024), Procedures (2016–2024), Segment revenues for 2016–2018, 2023–2024., Recurring revenue % for 2019–2024.
Estimated / Approximated: Recurring % before 2019, Procedures for 2015,Installed base for 2015,Segment revenues for 2019–2022.
The long-term trend is robust (more revenue, higher recurring %, more procedures, more systems), but the precise splits in the middle years (2015–2018 recurring %, 2019–2022 segment breakdowns) are approximations.
Sources:
https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/isrg-20241231.htm
https://bullfincher.io/companies/intuitive-surgical/revenue-by-segment